Masnavi Capital
Europe, Kyyiv, Ukraine, Kyiv
Description
Early Stage Investment Firm
Investor Profile
Masnavi Capital has made 5 investments, with 0 in the past 12 months and 0% as lead.
Stage Focus
- Seed (40%)
- Convertible Note (20%)
- Pre Seed (20%)
- Series Unknown (20%)
Country Focus
- United States (60%)
- Germany (20%)
- Singapore (20%)
'/%3e%3cuse xlink:href='%23a' transform='translate(288.889 -214.211)'/%3e%3cuse xlink:href='%23a' transform='translate(108 342.749)'/%3e%3cuse xlink:href='%23a' transform='translate(469.189 342.749)'/%3e%3c/svg%3e)
Industry Focus
- Health Care
- Biotechnology
- Life Science
- Mental Health
- Therapeutics
- Alternative Protein
- Consumer
- Food And Beverage
- Food Processing
- Consumer Electronics
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
